stockportfolio.pro
United Therapeutics Corporation Gross Profit 2008–2025
United Therapeutics Corporation (UTHR) annual gross profit by fiscal year, computed from SEC filings. Compound growth +15.1%/yr over 17 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $2.80B | 87.9% | +9.0% |
| FY 2024 | $2.57B | 89.2% | +24.0% |
| FY 2023 | $2.07B | 88.9% | +16.0% |
| FY 2022 | $1.78B | 92.2% | +14.2% |
| FY 2021 | $1.56B | 92.7% | +13.7% |
| FY 2020 | $1.38B | 92.7% | +3.3% |
| FY 2019 | $1.33B | 91.9% | -6.9% |
| FY 2018 | $1.43B | 87.8% | -11.8% |
| FY 2017 | $1.62B | 93.9% | +6.1% |
| FY 2016 | $1.53B | 95.5% | +9.3% |
| FY 2015 | $1.40B | 95.3% | +21.1% |
| FY 2014 | $1.15B | 89.5% | +18.2% |
| FY 2013 | $975.82M | 87.4% | +24.0% |
| FY 2012 | $786.83M | 85.9% | +20.6% |
| FY 2011 | $652.19M | 87.8% | +24.5% |
| FY 2010 | $524.03M | 88.4% | +65.4% |
| FY 2009 | $316.77M | 88.3% | +24.4% |
| FY 2008 | $254.54M | 90.4% | — |
Source: United Therapeutics Corporation SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for United Therapeutics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeUnited Therapeutics Corporation — frequently asked questions
What is United Therapeutics Corporation's gross profit?
United Therapeutics Corporation (UTHR) reported gross profit of $2.80B for fiscal year 2025, per its SEC filings.
How has United Therapeutics Corporation's gross profit changed over time?
Between fiscal 2008 and 2025, UTHR's gross profit grew at roughly 15.1% per year (compound annual rate), from $254.54M to $2.80B.
Where does this data come from?
Figures are computed from United Therapeutics Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.